MYC and colorectal carcinoma: Our data suggested that metformin reverses F. nucleatum-induced stemness by inhibiting the MYC/miR-361-5p/sonic hedgehog signaling axis, and then biologically and mechanistically reverting CRC chemoresistance induced by F. nucleatum.